this post was submitted on 15 Oct 2024
14 points (88.9% liked)

Futurology

1731 readers
130 users here now

founded 1 year ago
MODERATORS
top 7 comments
sorted by: hot top controversial new old
[–] PennyRoyal@sh.itjust.works 5 points 17 hours ago (2 children)

Is it speed? It’s speed, isn’t it?

[–] m4xie@lemmy.blahaj.zone 1 points 4 hours ago

It's working great for me, but I definitely have ADHD

[–] MeowZedong@lemmygrad.ml 1 points 16 hours ago

Looks like it's a monoclonal antibody design to decrease inflammation. The target is people with persistent, low levels of inflammation and major depression.

My institution doesn't give access, but my first question would be whether they accounted for treatment for the underlying cause of the inflammation. Persistent inflammation can cause all sorts of issues and I suppose a treatment for relief is good, but why does it exist? Treating the underlying condition seems more prudent unless they don't know the cause.

[–] TheTechnician27@lemmy.world 11 points 22 hours ago* (last edited 22 hours ago)

As opposed to a crappy content mill playing the telephone game.

[–] wizardbeard@lemmy.dbzer0.com 0 points 22 hours ago* (last edited 22 hours ago) (2 children)

Is this not how most depression medicines work?

I thought that's why they all have warnings about increased thoughts of suicide, and why some doctors hesitate to prescribe: the meds might give someone in a bad place just enough of a push to get moving that they follow through with suicide.

[–] MeowZedong@lemmygrad.ml 1 points 16 hours ago

No, not at all. This was looking at the effects of reducing inflammation on depression. Typical depression meds are meant to increase the availability of certain neurotransmitters such as serotonin.